Cours Acerus Pharmaceuticals Corporation Toronto S.E.
Actions
ASP
CA00444G4051
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,61 % | 672 Md | |
+25,87 % | 570 Md | |
-5,24 % | 360 Md | |
+16,49 % | 321 Md | |
+8,28 % | 300 Md | |
+7,09 % | 217 Md | |
-9,12 % | 204 Md | |
+5,01 % | 199 Md | |
-8,75 % | 149 Md |